Non‐pharmacological interventions in ID patients with challenging behaviours

Author:

Ogley Rob1,Javaid Amir2,Chear Li Juin3

Affiliation:

1. Dr Ogley is an ST6 doctor in training, currently Acting Consultant at Barnsley Adult Learning Disability Health Service

2. Dr Javaid is a Consultant Psychiatrist and Honorary Senior Clinical Lecturer based at Hull Learning Disability Service based at Townend Court

3. Dr Li is a Foundation Trainee Doctor working in Hull and Sheffield, UK.

Abstract

The STOMP (stopping over‐medication of people with a learning disability, autism or both with psychotropic medicines) initiative and NICE guidelines regarding the management of challenging behaviour in adults with intellectual disability (ID) promote the use of non‐pharmacological approaches ahead of medication, with an emphasis also on reducing dosage or stopping medication where appropriate. Here the authors report on the findings of a service evaluation looking at how often a community intellectual disability psychiatry clinic initiates non‐pharmacological approaches in cases referred for challenging behaviour, and importantly whether this impacts the dosages of medication subsequently prescribed.

Publisher

Wiley

Reference15 articles.

1. Use of positive behaviour support plan for challenging behaviour in autism

2. Stopping overmedication to manage challenging behaviour in LD ‐ STOMP disability – STOMP (pilot study)

3. GloverG WilliamsR BranfordD et al. Prescribing of psychotropic drugs to people with learning disabilities and/or autism by general practitioners in England (https://webarchive.nationalarchives.gov.uk/ukgwa/20160704152031/https:/www.improvinghealthandlives.org.uk/publications/1248/Prescribing_of_psychotropic_medication_for_people_with_learning_disabilities_and_autism; accessed 5 April 2024).

4. Psychotropic medication use for challenging behaviors in persons with intellectual disabilities: An overview

5. BanerjeeS.The use of antipsychotic medication for people with dementia: Time for action (http://psychrights.org/research/digest/nlps/BanerjeeReportOnGeriatricNeurolepticUse.pdf; accessed 5 April 2024).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3